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Table 1. Major laboratory parameters of the index patient.
Day 1 Day 11 Day 35
White blood count ( 109) 27.95 10.77 10.13
Differential leucocyte
count (%)
N78.1, L20.8,
M0.2, E0.4
N78.7, LI6.5,
M4.4, E0
N70.6, L21.5,
M6.7, E1.1
Hemoglobin (g/L) 98 92 85
Platelet ( 109) 258 163 154
Bilirubin (mmol/L) 17.7 6.8 6.6
Bilirubin(conjugated)
(mmol/L)
6.1 4 3.9
Protein (g/L) 54.6 46.5 57.3
Albumin (g/L) 28 25.4 28.6
Aspartate
aminotransferase (U/L)
77 13 16
Alanine
aminotransferase (U/L)
378 31 31
Alkaline phosphatase (U/L) 261 83 62
Gamma-glutamyl
transpeptidase (U/L)
129 62 43
Serum urea (mmol/L) 42.8 26.9 17.16
Serum creatinine (mmol/L) 1336 551 387
Urinary protein
excretion (g/d)
1.511 1.299 1.009
Red blood cells per
high-power field
1.27 1.65 282
White blood cells per
high-power field
15.69 6.75 3.25
Epithelial cells per
high-power field
17.82 1.05 0.53
Specific gravity of urine 1.010 1.012 1.006
Urinary osmotic pressure
(mOsm/kg H2O)
409 483 261
N, neutrophil; L, lymphocyte; E, eosinophil; M, monocyte.
S68 Other Specific Nephropathieshttp://dx.doi.org/10.1016/j.hkjn.2015.09.030Table 1. Baseline demographics, treatment details and clinical outcome
(n Z 23).
Age, years 73.1 5.1
Gender, male / female 8 / 15
Body weight, kg 63.1 12.3
Hypertension, n (%) 17 (77.3%)
Diabetes mellitus, n (%) 2 (8.7%)
Charlson’s Comorbidity Index score 4.6 1.7
Diagnosis, n (%)
Minimal change nephropathy 4 (17.4%)
Primary focal segmental glomerulosclerosis 3 (13.0%)
IgA nephropathy 1 (4.3%)
Lupus nephritis 2 (8.7%)
Crescentic glomerulonephritis 5 (21.7%)
Post-infectious glomerulonephritis 1 (4.3%)
Membranous nephropathy 7 (30.4%)
Immunosuppressant, n (%)
Steroid 23 (100%)
Cyclosporin 7 (30.4%)
Mycophenolate mofetil 2 (8.7%)
Cyclophosphamide 4 (17.4%)0275
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Objective: To assess the changing prevalence of idiopathic membranous ne-
phropathy (iMN) in Chinese patients undergoing renal biopsy from our
nephrology center.
Methods: The records of 8559 consecutive native renal biopsies performed in
adults (14 years of age) in the First Affiliated Hospital of Zhejiang Univer-
sity between 2005 and 2014 were retrospectively analysed. The criteria for
renal biopsy and pathologic diagnosis were kept unchanged. The patients
were grouped according to a 5-year interval, 2005e2010 (period 1),
2010e2014 (period 2), and divided into four age groups (14e24, 25e44,
45e59,  60 years old).
Results: Among 8559 specimens, 6336 (74.03%) were diagnosed as primary
glomerular diseases (PGD). IgA nephropathy (IgAN) was the most common
PGD (55.67%), with a significant decrease in the period 2 (50.82% vs.
64.79%, P < 0.001). The prevalence of iMN in PGD increased rapidly
from 16.59% in period 1 to 25.21% in period 2 in all groups of age (P <
0.001). In patients aged 45e59 years, the proportion of renal histopathol-
ogy stage I and stage II of iMN in PGD was significantly higher in period 2
than in period 1 (20.54% vs. 30.29%, P < 0.001). 51.08% of petients with
iMN presented with nephrotic syndrome, the remainder presented with
chronic nephritis syndrome (28.11%) and asymptomatic urinary abnormal-
ity (20.81%). There were no significant differences in clinical characteris-
tics including age, gender, hypertension, serum cholesterol, serum
albumin and glomerular filtration rate between the two periods (P >
0.05).Conclusion: The prevalence of iMN in PGD in our nephrology center has
increased significantly over the past 10 years. The increase of adult iMN is
mainly due to the increase in the early stages of iMN in middle-aged patients.http://dx.doi.org/10.1016/j.hkjn.2015.09.0310278
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Objective: Glomerulonephritis is not uncommon among elderly and immuno-
suppressive treatment is often needed to achieve remission. Compared to
young patients, elderly might bear higher complication risks especially infec-
tion. We looked into the adverse events among elderly who received immu-
nosuppressive therapy.
Methods: We retrospectively reviewed all elderly (age 65 years) who under-
went renal biopsy at our institution between 2007 and 2014. Patients diagnosed
to have glomerulonephritis were included. Their baseline demographics, diag-
nosis, immunosuppressants received, details of infection-related hospitaliza-
tion, other clinical outcomes including treatment response, development
into end-stage renal disease (ESRD) or death were retrieved.
Results: 27 patients were identified and 23 of them had received immuno-
suppressants. Their total follow-up duration was 764.4 patient-months,
which included 450.8 patient-months of immunosuppressive treatment.
Baseline demographics, treatment details, infectious complications and
other clinical outcomes of the cohort are shown in Table 1. During follow-
up, there were 60 hospitalizations, among which 25 episodes (41.7%) were
due to infections involving 12 patients (51.2%). Overall infection-related hos-
pitalization rate was once every 30.6 patient-months (i.e. 0.39 episodes per
year). Among the 12 patients, median onset of infection was 3.2 months (IQR
1.6e45.3) after starting immunosuppressants. Eventually, 4 patients (17.4%)
progressed to ESRD and 5 patients (21.7%) died. 60% mortality was attributed
to infections. Comparing patients with and without infections, patients
complicated with infections had lower body weight, higher baseline serum
creatinine and more non-responders to treatment (Table 2). Binary logistic
regression confirmed non-responder (OR 10.5, 95% CI 1.4e81.1, p Z 0.02)
as the only independent risk factor for infectious complications.
Conclusion: Immunosuppressive treatment is associated with infectious
complication risks among elderly suffering from glomerulonephritis. Patients
with poor clinical response are particularly prone to developing infections.
Over-aggressive treatment should be avoided in this high-risk group in order
to minimize infection risks and mortality.
